Viewing Study NCT07078305


Ignite Creation Date: 2025-12-25 @ 3:10 AM
Ignite Modification Date: 2025-12-31 @ 6:37 PM
Study NCT ID: NCT07078305
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-22
First Post: 2025-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module